Cartesian Therapeutics Inc
SWB:1S7
Cartesian Therapeutics Inc
SWB:1S7
Price:
13.242
EUR
Market Closed
Market Cap:
€8.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Cartesian Therapeutics Inc
SWB:1S7
|
US |
|
I
|
ImmunoGen Inc
XBER:IMU
|
US |
|
B
|
Booz Allen Hamilton Holding Corp
LSE:0HOT
|
US |
|
A
|
Africa Oil Corp
TSX:MER
|
CA |
|
P
|
Pilgrims Pride Corp
F:6PP
|
US |
|
R
|
Renesas Electronics Corp
XBER:NEN
|
JP |
|
M
|
Myer Holdings Ltd
F:30M
|
AU |
|
Wuxi Hyatech Co Ltd
SSE:688510
|
CN |
Wall St Price Targets
1S7 Price Targets Summary
Cartesian Therapeutics Inc
Cartesian Therapeutics Inc
Wall Street analysts forecast 1S7 stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 1S7 is 61.588 EUR with a low forecast of 28.84 EUR and a high forecast of 82.45 EUR.
Lowest Forecast
Price Target
28.84
EUR
118% Upside
Average Forecast
Price Target
61.588
EUR
365% Upside
Highest Forecast
Price Target
82.45
EUR
523% Upside
Cartesian Therapeutics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 1S7's stock price target?
Price Target
61.588
EUR
61.588
EUR
According to Wall Street analysts, the average 1-year price target for 1S7 is 61.588 EUR with a low forecast of 28.84 EUR and a high forecast of 82.45 EUR.
What is the Revenue forecast for Cartesian Therapeutics Inc?
Projected CAGR
105%
105%
Over the last 10 years, the compound annual growth rate for Revenue has been -7%. The projected CAGR for the next 8 years is 105%.
